Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Models for mature T-cell lymphomas—A critical appraisal of experimental systems and their contribution to current T-cell tumorigenic concepts
Kathrin Warner, Giuliano Crispatzu, Nabil Al-Ghaili, et al.
Critical Reviews in Oncology/Hematology (2013) Vol. 88, Iss. 3, pp. 680-695
Closed Access | Times Cited: 17

Showing 17 citing articles:

Actionable perturbations of damage responses by TCL1/ATM and epigenetic lesions form the basis of T-PLL
Alexandra Schrader, Giuliano Crispatzu, Sebastian Oberbeck, et al.
Nature Communications (2018) Vol. 9, Iss. 1
Open Access | Times Cited: 91
Discovery of novel drug sensitivities in T-PLL by high-throughput ex vivo drug testing and mutation profiling
Emma Andersson, S. Pützer, Bhagwan Yadav, et al.
Leukemia (2017) Vol. 32, Iss. 3, pp. 774-787
Closed Access | Times Cited: 90
STAT5BN642H is a driver mutation for T cell neoplasia
Hà Phạm, Barbara Maurer, Michaela Prchal‐Murphy, et al.
Journal of Clinical Investigation (2017) Vol. 128, Iss. 1, pp. 387-401
Open Access | Times Cited: 72
Polymerase-mediated ultramutagenesis in mice produces diverse cancers with high mutational load
Hao‐Dong Li, Ileana Cuevas, Musi Zhang, et al.
Journal of Clinical Investigation (2018) Vol. 128, Iss. 9, pp. 4179-4191
Open Access | Times Cited: 70
Development of HDAC Inhibitors Exhibiting Therapeutic Potential in T-Cell Prolymphocytic Leukemia
Krimo Toutah, Nabanita Nawar, Sanna Timonen, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 12, pp. 8486-8509
Open Access | Times Cited: 34
Challenging perspectives on the cellular origins of lymphoma
Tim Malcolm, Daniel J. Hodson, Elizabeth Macintyre, et al.
Open Biology (2016) Vol. 6, Iss. 9, pp. 160232-160232
Open Access | Times Cited: 45
Targeting Interleukin-2-inducible T-cell Kinase (ITK) and Resting Lymphocyte Kinase (RLK) Using a Novel Covalent Inhibitor PRN694
Yiming Zhong, Shuai Dong, Ethan Strattan, et al.
Journal of Biological Chemistry (2015) Vol. 290, Iss. 10, pp. 5960-5978
Open Access | Times Cited: 41
High activation of STAT5A drives peripheral T-cell lymphoma and leukemia
Barbara Maurer, Harini Nivarthi, Bettina Wingelhofer, et al.
Haematologica (2019) Vol. 105, Iss. 2, pp. 435-447
Open Access | Times Cited: 40
Re-activation of mitochondrial apoptosis inhibits T-cell lymphoma survival and treatment resistance
S Spinner, Giuliano Crispatzu, J-H Yi, et al.
Leukemia (2016) Vol. 30, Iss. 7, pp. 1520-1530
Closed Access | Times Cited: 29
Transformation of mouse T cells requires MYC and AKT activity in conjunction with inhibition of intrinsic apoptosis
Kari Högstrand, Stephanie Darmanin, TachaZi Plym Forshell, et al.
Oncotarget (2018) Vol. 9, Iss. 30, pp. 21396-21410
Open Access | Times Cited: 7
Take (STAT)5: jazzing up T-cell leukemia
Pierluigi Porcu, Jason A. Dubovsky
Blood (2014) Vol. 124, Iss. 9, pp. 1383-1384
Open Access | Times Cited: 6
Burrowing through the Heterogeneity: Review of Mouse Models of PTCL-NOS
Christine E. Cutucache, Tyler A. Herek
Frontiers in Oncology (2016) Vol. 6
Open Access | Times Cited: 4
In Vivo and Ex Vivo Patient‐Derived Tumor Xenograft Models of Lymphoma for Drug Discovery
Maria Teresa Cacciapuoti, Luca Vincenzo Cappelli, Danilo Fiore, et al.
Current Protocols (2021) Vol. 1, Iss. 4
Closed Access | Times Cited: 4
An evolutionary stability perspective on oncogenesis control in mature T-cell populations
Hans H. Diebner, Jörg Kirberg, Ingo Roeder
Journal of Theoretical Biology (2015) Vol. 389, pp. 88-100
Closed Access | Times Cited: 2
Patient-Derived Tumor Xenografts in Hematologic Disorders
Marco Pizzi, Giorgio Inghirami
Elsevier eBooks (2017), pp. 305-339
Closed Access | Times Cited: 2
Concepts in mature T-cell lymphomas – highlights from an international joint symposium on T-cell immunology and oncology
Marco Herling, Benjamin Rengstl, René Scholtysik, et al.
Leukemia & lymphoma/Leukemia and lymphoma (2016) Vol. 58, Iss. 4, pp. 788-796
Closed Access | Times Cited: 1
The Role of Tumour Necrosis Factor Receptor Family Members CD137 (4-1BB) and CD30 in Antiviral T Cell Responses
Angela Zhou
(2018)
Closed Access
Page 1

Scroll to top